admin – Page 8056 – Get News Story

Face Yoga Method Unveils Its Rejuvenating 5-Day Challenge To Combat Eye Bags and Dark Circles

Face Yoga Method’s innovative 5-Day Challenge is designed to alleviate the exhausting holiday stress that takes a toll on one’s natural glow.

As the holiday season approaches, Face Yoga Method calls for prioritizing self-care with a transformative 5-Day Challenge on Zoom aimed at rejuvenating one’s face and combating eye bags and dark circles. Amidst the chaos of holiday preparations, the renowned Face Yoga Expert, Fumiko, and her team of Certified Pro-Aging Coaches aim to guide their clients toward a radiant and refreshed holiday look.

Relieving Holiday Stress

The holiday season, while joyous, often brings fatigue and stress that manifests on the face. Dark under-eye bags and circles can dull people’s festive glow, making them appear tired even when they’re not. Face Yoga Method addresses this issue with a holistic approach, providing quick and effective 30-minute Face Yoga classes on Zoom for only $27. These sessions, hosted by Fumiko and her team, promise visible results in just five days.

Starting from December 11th to 15th, participants will engage in daily Face Yoga online tutorials to melt away stress and tiredness, ensuring they put their best face forward for holiday gatherings. The 5-Day Challenge offers accessibility, featuring beginner-friendly classes that cater to Face Yoga Newbies and experienced practitioners alike.

Speaking to Face Yoga creator Fumiko Takatsu “During the holiday season, it’s easy to get caught up in the hustle and bustle of making everything perfect for others. At Face Yoga Method, we believe making time for yourself is equally important. Our 5-Day Challenge is a gift you give to yourself.”

Bite-Sized Proven Face Yoga Routines For A Youthful Glow

Unlike random YouTube tutorials, this 5-Day Challenge to Get Rid of Eye Bags and Dark Circles is designed to get results fast. The challenge offers live 30-minute classes on Zoom, with extended 7-day access to replays. Participants will also gain entry into an exclusive Facebook Group, fostering connections with other Face Yoga Challengers and Q&A sessions with expert coaches.

By the end of the challenge, participants can expect a picture-perfect glow, depuffed under-eye bags, and renewed confidence in their appearance. The Face Yoga Method goes beyond surface-level treatments, ensuring a comprehensive transformation from the inside out.

Conclusion

Face Yoga Method, founded by Fumiko Takatsu, is a transformative approach to rejuvenating faces. With a focus on holistic wellbeing, the method offers accessible programs to help individuals achieve lasting results and a renewed sense of confidence.

Media Contact
Company Name: Face Yoga Method
Contact Person: Fumiko Takatsu
Email: Send Email
Phone: (314) 391 8464
Country: United States
Website: https://go.faceyogamethod.com/5-day-challenge

Remote Nursing Jobs Massachusetts Website Features New Listings Daily

RemoteNursingJobs.com offers 400+ state-specific remote nurse jobs on their website, which are updated daily. It is among the largest, dedicated – and user-friendly – resources for nursing jobs making job searches and recruitment convenient.

RemoteNursingJobs.com is pleased to announce that new jobs are posted daily in a range of positions and locations, including for Massachusetts. The website makes searching for preferred remote nursing positions easy and convenient. The jobs board is set up to make it possible to search by type of job, certification level, location, and experience. There is also information about salary averages in each state and job prospects by location.

Nurses and nursing-related positions such as RNs represent a career opportunity for the present and the foreseeable future. The jobs board is a dedicated, easy-to-use, and comprehensive resource for Remote Nursing Jobs. The Remote Nursing Jobs Massachusetts category is just one of dozens of searchable filters.

The goal of the Remote RN Jobs Massachusetts listings is to make hiring less challenging and to create a venue where it is easy to connect talented nurses with the right job opportunities. The current recruitment process can be frustrating thanks to outdated technology, which turns hiring managers and candidates off. The remote nursing jobs site managers believe that a streamlined recruitment process and better technology are possible. The job board provides a platform that makes it easy for nurses to find job opportunities, simple for hiring teams to collaborate, and for recruiting vendors to be just a click away.

Additional details are available at https://remotenursingjobs.com/location/massachusetts/

At the job board for Remote Nursing Jobs, the founders strive to revolutionize the recruitment process, giving nurses and employers the tools they need to make better connections. The site owners are passionate about providing a platform that enables nurses to find a job they love and employers to find the talent they need.

Different types of companies and organizations use remote professionals to fulfill hiring and staffing needs. The entities range from healthcare companies to insurance firms to specialty companies. A few of the companies leading the field in remote job opportunities for nurses include BlueCross BlueShield Association, CVS, Henry Ford Health, Kaiser Permanente, and United Health Group. These companies are a compilation of the most popular ones that offer work-from-home remote nursing jobs, but it is not a definitive list. The pages are updated as needed.

Users of the website can search by categories, such as experience level, profession, license type, and state. Experience level filters include new graduates, no experience, one year, one to three years, three to five years, five to ten years, and more than ten years. Filters for various nursing professions include geriatric nursing, dermatology nursing, substance abuse nursing, and many other specialties. Jobs sorted by license include remote RN jobs, Remote NP jobs, remote LPN/LVN jobs, and remote PA jobs. In addition to the above filters, searching for jobs by state is possible.

The website also provides additional information that can be helpful regardless of the type of nursing job under consideration. Remote jobs are growing in popularity in many areas. Face-to-face nursing is likely to continue, but there is a growing emphasis on remote consultations and preventative medicine techniques. There are full-time and part-time positions open. With the many opportunities being posted to the website and updated daily, it is an excellent way to explore possibilities for relocating, moving to remote work, or checking out pay levels. The latest salaries, opportunities, and trends statistics are available on the website.

About the Site:

RemoteNursingJobs.com offers a range of opportunities for remote nursing jobs across the United States. Dozens of specific jobs are posted, and the website user can also use filters to focus on particular types of open positions. The comprehensive nature of the website makes it possible for professionals to make informed career decisions with the most current information.

Media Contact
Company Name: RemoteNursingJobs.com
Contact Person: Gordon Jay
Email: Send Email
City: Santa Barbara
State: California 93110
Country: United States
Website: remotenursingjobs.com

Denver Emergency Dentist: Rapid and Reliable Dental Care in Critical Times

Located in Arvada, Colorado, Denver Emergency Dentist is a dependable facility providing exceptional care for dental emergencies to residents in and around Denver.

Dental emergencies, from severe toothaches and sudden swelling to broken teeth or other injuries to the mouth, can occur unexpectedly. Time is of the essence when dealing with dental emergencies, and getting prompt professional help not only addresses urgent dental issues and alleviates pain but prevents further damage.

In times of dental distress, the residents of Arvada and its surrounding areas now have a trusted dental service to rely on. The Denver emergency dentist is a sophisticated, easy-to-access dental facility that provides prompt and professional oral care, offering instant and effective treatment for patients experiencing urgent dental issues.

Catering to the nature of dental emergencies, this Denver emergency dental center is open 24/7 to walk-in patients and is fully equipped and ready to provide off-facility dental services anywhere in the city and its areas of coverage to treat various dental issues or accidents. The center offers a range of emergency dental services, including abscessed tooth removal, root canals, dental bridges, broken retainers, emergency fillings, broken fillings, tooth extractions, broken teeth, fractured teeth, and even swollen jaw problems.

With a team of highly trained, skilled, and compassionate dentists and support staff well-versed in handling diverse dental emergencies, patients with dental phobia can relax with the gentle care the team provides and trust them without worry.

For more information, visit https://emergencydentalofdenver.co/

Assessing and addressing dental emergencies with precision and efficiency, the team offers relief to patients when they need it the most, following which, they can receive post-treatment care to ensure the best outcome of the procedures.

As the city’s premier emergency walk-in dentist center, Denver Emergency Dentist is dedicated to staying at the forefront of dental emergency care, providing the community with a comprehensive range of emergency and general dental services, from tooth extraction and dental implants to cosmetic dentistry, and more.

Denver Emergency Dentist handles more than dental emergencies, offering excellent general dental care services. The state-of-the-art facility at Denver Emergency Dentist is fully equipped with the latest tools. Equipment such as computerized tomography, digital impressions, and implant placement systems, facilitate accurate diagnoses and the best treatments using advanced technology.

Patient care and a positive treatment experience are high priorities with Denver Emergency Dentist, with an emphasis on providing top-quality, personalized treatments with clear communication and transparency. Patients can expect thorough explanations of the diagnosis, treatment options, and associated costs, allowing individuals to be actively involved in dental care decisions and fostering trust.

The center’s commitment to preserving the community’s oral health extends to making treatments more affordable by offering patients convenient payment plans and finance options. Additionally, Denver Emergency Dentist is dedicated to educating the community about oral health and its website provides ample resources and information on recognizing and managing dental emergencies, equipping individuals with knowledge that can make a difference in critical situations.

Denver Emergency Dentist provides dental solutions when needed on short notice. With over a decade of experience and a loyal clientele that testifies to its top-notch services with excellent reviews and 5-star ratings.

With its skilled team, advanced facility, and unwavering commitment to patient-centric care, the clinic has become the go-to destination for urgent dental treatment in Denver and its surrounding areas.

About the Center:

Denver Emergency Dentist is a reliable, state-of-the-art facility providing emergency and general dental care with over ten years of experience. It is located in Arvada, Colorado, and serves Denver and its surrounding areas. The clinic has a team of highly trained, efficient, and compassionate dentists and support staff that provide immediate, gentle, and patient-centric care. With a comprehensive range of services, including tooth extraction, dental implants, cosmetic dentistry, and more, Denver Emergency Dentist has earned a stellar reputation for its time-sensitive and effective treatments applying advanced technology. It aims to make treatments available to all in the community and offers convenient payment and finance options.

Media Contact
Company Name: Denver Emergency Dentist
Contact Person: Thiago
Email: Send Email
Phone: (720) 730-2939
City: Arvada
State: CO 80002
Country: United States
Website: https://emergencydentalofdenver.co/

HER2-Positive Breast Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, and Treatment Outlook | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, HER2-Positive Breast Cancer pipeline constitutes 60+ key companies continuously working towards developing 65+ HER2-Positive Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The HER2-Positive Breast Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

“HER2-Positive Breast Cancer Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HER2-Positive Breast Cancer Market.

Some of the key takeaways from the HER2-Positive Breast Cancer Pipeline Report:

Companies across the globe are diligently working toward developing novel HER2-Positive Breast Cancer treatment therapies with a considerable amount of success over the years.
HER2-Positive Breast Cancer companies working in the treatment market are AdaptVac, Voronoi, Dizal Pharmaceuticals, Alteogen, Inc, Precirix, BioInvent International, Miracogen Inc., Alphamab BioPharmaceuticals, CSPC ZhongQi Pharmaceutical Technology, Jiangsu HengRui Medicine Co., Ltd, Shanghai Henlius Biotech, Ambrx, Genentech, Innate Pharma, EirGenix, GeneQuantum Healthcare Co., Ltd., and others, are developing therapies for the HER2-Positive Breast Cancer treatment

Emerging HER2-Positive Breast Cancer therapies in the different phases of clinical trials are- ES2B C001, VRN 10, DZD1516, ALT-P7, CAM-H2, BI-1607+ trastuzumab, MRG002 Shanghai, KN-026 Jiangsu, DP 303c, SHR-A1811, HLX11, ARX 788, Inavolisib, Monalizumab, Pertuzumab, GQ1001, and others are expected to have a significant impact on the HER2-Positive Breast Cancer market in the coming years.
In September 2022, Celltrion has entered into a collaboration to co-develop Abpro’s cancer molecule ABP-102, with a deal potentially valued at $1.75 billion. Abpro, located in Massachusetts, is working on ABP-102 as an antibody targeting T-cell activity in HER2-positive breast cancer patients. Celltrion will assume full responsibility for developing and marketing the pre-clinical molecule. Upon approval of ABP-102, Abpro stands to receive up to $1.75 billion in sales and $10 million in milestone payments.
In September 2022, Artiva Biotherapeutics, Inc. declared that the U.S. Food and Drug Administration (FDA) has approved the company’s investigational new drug (IND) application for AB-201. AB-201 represents the initial systemically administered CAR-NK cell therapy designed to target prevalent HER2-positive cancer types, such as breast and gastric carcinomas.
In August 2022, ALX Oncology Holdings Inc. and Quantum Leap Healthcare Collaborative™ have announced the selection of ALX Oncology’s advanced CD47 blocker, evorpacept, for inclusion in a new investigational treatment phase within the I-SPY-P1 TRIAL. This phase 1 (open-label), multi-center study arm, sponsored by Quantum Leap, aims to assess evorpacept in combination with ENHERTU® (fam-trastuzumab deruxtecan-nxki), an antibody-drug conjugate targeting HER2, for patients with unresectable or metastatic HER2-positive and HER2-low breast cancer, focusing on evaluating safety, tolerability, and efficacy of this drug combination.
In August 2022, The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) has extended the conditional marketing authorization for fam-trastuzumab deruxtecan-nxki (Enhertu) for use as a single agent in adult patients across Great Britain. This includes individuals diagnosed with HER2-positive unresectable or metastatic breast cancer who have undergone one or more prior HER2-based treatments.
In July 2022, Byondis B.V. revealed that the U.S. Food & Drug Administration (FDA) has approved the company’s submission of a Biologics License Application (BLA) for [vic-]trastuzumab duocarmazine (SYD985). This application targets patients with HER2-positive unresectable locally advanced or metastatic breast cancer (MBC). The company has been assigned a Prescription Drug User Fee Act (PDUFA) action date scheduled for May 12, 2023.
In July 2022, Jiangsu HengRui Medicine Co., Ltd. has commenced a Phase III, multicenter, randomized, open-label, parallel-controlled study titled ‘SHR-A1811 Versus Pyrotinib in Combination With Capecitabine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane’.
In June 2022, The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) advised the approval of fam-trastuzumab deruxtecan-nxki (Enhertu) as a standalone treatment for individuals diagnosed with metastatic HER2-positive breast cancer, having previously undergone at least one anti–HER2-based treatment.
In February 2022, Alphamab Oncology reported the publication of data in Clinical Cancer Research regarding a phase I clinical trial on their proprietary HER2 bispecific antibody, KN026, designed for treating HER2-positive metastatic breast cancer. Titled ‘First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer,’ this updated information from the China Phase I clinical study indicated that KN026 was well-tolerated, displayed promising early-stage tumor response, and exhibited potential effectiveness among patients with HER2-positive metastatic breast cancer (MBC) who had previously received at least one anti-HER2 therapy.

HER2-Positive Breast Cancer Overview

HER2-positive Breast cancer is the most common cancer in women worldwide and the second most common cancer worldwide. One in five breast cancers had HER2-positive status. Compared to other types of breast cancer, HER2-positive breast cancers are more aggressive.

Get a Free Sample PDF Report to know more about HER2-Positive Breast Cancer Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/her2-positive-breast-cancer-pipeline-insight

Emerging HER2-Positive Breast Cancer Drugs Under Different Phases of Clinical Development Include:

ES2B C001: AdaptVac
VRN 10: Voronoi
DZD1516: Dizal Pharmaceuticals
ALT-P7: Alteogen, Inc
CAM-H2: Precirix
BI-1607+ trastuzumab: BioInvent International
MRG002 Shanghai: Miracogen Inc.
KN-026 Jiangsu: Alphamab BioPharmaceuticals
DP 303c: CSPC ZhongQi Pharmaceutical Technology
SHR-A1811: Jiangsu HengRui Medicine Co., Ltd
HLX11: Shanghai Henlius Biotech
ARX 788: Ambrx
Inavolisib: Genentech
Monalizumab: Innate Pharma
Pertuzumab: EirGenix
GQ1001: GeneQuantum Healthcare Co., Ltd.

HER2-Positive Breast Cancer Route of Administration

HER2-Positive Breast Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Intravenous
Subcutaneous
Parenteral
Topical

HER2-Positive Breast Cancer Molecule Type

HER2-Positive Breast Cancer Products have been categorized under various Molecule types, such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

HER2-Positive Breast Cancer Pipeline Therapeutics Assessment

HER2-Positive Breast Cancer Assessment by Product Type
HER2-Positive Breast Cancer By Stage and Product Type
HER2-Positive Breast Cancer Assessment by Route of Administration
HER2-Positive Breast Cancer By Stage and Route of Administration
HER2-Positive Breast Cancer Assessment by Molecule Type
HER2-Positive Breast Cancer by Stage and Molecule Type

DelveInsight’s HER2-Positive Breast Cancer Report covers around 65+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further HER2-Positive Breast Cancer product details are provided in the report. Download the HER2-Positive Breast Cancer pipeline report to learn more about the emerging HER2-Positive Breast Cancer therapies

Some of the key companies in the HER2-Positive Breast Cancer Therapeutics Market include:

Key companies developing therapies for HER2-Positive Breast Cancer are – Roche Pharma AG, Dizal Pharmaceuticals, Greenwich LifeSciences, Ambrx, Alteogen, Suzhou Zanrong Pharma Limited, AstraZeneca, Shanghai Henlius Biotech, GeneQuantum Healthcare (Suzhou) Co., Ltd., Klus Pharma Inc.,Shanghai Miracogen Inc., Carisma Therapeutics Inc, Triumvira Immunologics, Inc., Precirix, Seagen Inc., CSPC ZhongQi Pharmaceutical Technology Co., Jiangsu Alphamab Biopharmaceuticals Co., Ltd, Zymeworks Inc., Pieris Pharmaceuticals, Inc., Orum Therapeutics, RemeGen Co., Ltd., and others.

HER2-Positive Breast Cancer Pipeline Analysis:

The HER2-Positive Breast Cancer pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of HER2-Positive Breast Cancer with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for HER2-Positive Breast Cancer Treatment.
HER2-Positive Breast Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
HER2-Positive Breast Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the HER2-Positive Breast Cancer market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about HER2-Positive Breast Cancer drugs and therapies

HER2-Positive Breast Cancer Pipeline Market Drivers

Increase in prevalence of Breast Cancer and its recurrence, robust Pipeline, higher Indulgence of Immunotherapy are some of the important factors that are fueling the HER2-Positive Breast Cancer Market.

HER2-Positive Breast Cancer Pipeline Market Barriers

However, side effects associated with the treatment, high cost of the treatment and other factors are creating obstacles in the HER2-Positive Breast Cancer Market growth.

Scope of HER2-Positive Breast Cancer Pipeline Drug Insight

Coverage: Global
Key HER2-Positive Breast Cancer Companies: AdaptVac, Voronoi, Dizal Pharmaceuticals, Alteogen, Inc, Precirix, BioInvent International, Miracogen Inc., Alphamab BioPharmaceuticals, CSPC ZhongQi Pharmaceutical Technology, Jiangsu HengRui Medicine Co., Ltd, Shanghai Henlius Biotech, Ambrx, Genentech, Innate Pharma, EirGenix, GeneQuantum Healthcare Co., Ltd., and others
Key HER2-Positive Breast Cancer Therapies: ES2B C001, VRN 10, DZD1516, ALT-P7, CAM-H2, BI-1607+ trastuzumab, MRG002 Shanghai, KN-026 Jiangsu, DP 303c, SHR-A1811, HLX11, ARX 788, Inavolisib, Monalizumab, Pertuzumab, GQ1001, and others
HER2-Positive Breast Cancer Therapeutic Assessment: HER2-Positive Breast Cancer current marketed and HER2-Positive Breast Cancer emerging therapies
HER2-Positive Breast Cancer Market Dynamics: HER2-Positive Breast Cancer market drivers and HER2-Positive Breast Cancer market barriers

Request for Sample PDF Report for HER2-Positive Breast Cancer Pipeline Assessment and clinical trials

Table of Contents

1. HER2-Positive Breast Cancer Report Introduction

2. HER2-Positive Breast Cancer Executive Summary

3. HER2-Positive Breast Cancer Overview

4. HER2-Positive Breast Cancer- Analytical Perspective In-depth Commercial Assessment

5. HER2-Positive Breast Cancer Pipeline Therapeutics

6. HER2-Positive Breast Cancer Late Stage Products (Phase II/III)

7. HER2-Positive Breast Cancer Mid Stage Products (Phase II)

8. HER2-Positive Breast Cancer Early Stage Products (Phase I)

9. HER2-Positive Breast Cancer Preclinical Stage Products

10. HER2-Positive Breast Cancer Therapeutics Assessment

11. HER2-Positive Breast Cancer Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. HER2-Positive Breast Cancer Key Companies

14. HER2-Positive Breast Cancer Key Products

15. HER2-Positive Breast Cancer Unmet Needs

16 . HER2-Positive Breast Cancer Market Drivers and Barriers

17. HER2-Positive Breast Cancer Future Perspectives and Conclusion

18. HER2-Positive Breast Cancer Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: HER2-Positive Breast Cancer Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, and Treatment Outlook | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx

Karl Frank Receives Prestigious 2023 Five Star Wealth Manager Award

Denver CO – A momentous achievement in the financial industry, Karl Frank of A&I Wealth Management is proud to announce that he has been honored with the esteemed 2023 Five Star Wealth Manager award. This recognition, bestowed by Five Star Professional and prominently featured in the pages of 5280 Magazine, attests to Karl Frank’s unwavering commitment to providing exceptional service and value to his clients.

A Commitment to Excellence

Earning the Five Star Wealth Manager award is a testament to Karl Frank’s dedication to his clients and his exemplary performance in the financial services sector. The accolade reflects not only his expertise in wealth management but also his commitment to upholding the highest standards of integrity, professionalism, and client satisfaction.

Five Star Professional’s Rigorous Selection Process

Five Star Wealth Managers are chosen through a meticulous research methodology that includes ten objective criteria, ensuring that only the most outstanding individuals in the industry receive this prestigious honor. This recognition in the pages of 5280 Magazine showcases Karl Frank’s exceptional contributions to the Denver-area investment community.

Congratulations Pour In

As news of Karl Frank’s achievement spreads, colleagues, clients, and industry peers are coming together to extend their heartfelt congratulations. The award not only reflects individual excellence but also serves as a beacon for the entire financial community, setting a high standard for professionalism and client-focused service.

A Message from Karl Frank

“I am truly honored to receive the 2023 Five Star Wealth Manager award. This recognition reinforces our unwavering commitment to our clients and underscores the dedication of our entire team. I would like to express my sincere gratitude to Five Star Professional for this esteemed acknowledgment,” says Karl Frank, Financial Advisor at A&I Wealth Management.

About Five Star Professional

Five Star Professional is a leading independent research firm that identifies and recognizes outstanding professionals in various industries, including wealth management. The firm’s rigorous selection process ensures that those awarded the Five Star designation represent the pinnacle of excellence in their respective fields.

Connect with Karl Frank: https://www.assetsandincome.com/our-team/karl-frank/

LinkedIn: https://www.linkedin.com/in/karlfrank/

Youtube: https://www.youtube.com/channel/UCakfq8mzV3Z0aLaB7JX_RQA

https://www.facebook.com/AandIFinancialServices/

In celebrating Karl Frank’s remarkable achievement, Five Star Professional congratulates not only him but also all the 2023 Five Star Wealth Managers who have demonstrated excellence, dedication, and a commitment to advancing the standards of the financial industry.

Media Contact
Company Name: A&I Wealth Management
Contact Person: Karl
Email: Send Email
Phone: +1 303-690-5070
Address:9605 Kingston Court Suite 190
City: Lone Tree
State: Colorado
Country: United States
Website: https://www.assetsandincome.com/

Physicians for You Leads the Way in Revolutionizing Rural Healthcare with Innovative Staffing Solutions

Toronto, ON – Physicians for You, a prominent healthcare organization, is taking significant strides in addressing the challenges faced by remote and rural healthcare clinics. With a mission to ensure accessible healthcare services for all, regardless of geographic location, Physicians for You has been at the forefront of the transformation in healthcare delivery.

In recent years, the landscape of healthcare delivery has been undergoing a transformative shift, with remote work emerging as a significant solution to various challenges faced by the industry. While remote work has gained prominence across multiple sectors, it has proven to be especially vital in healthcare, particularly for clinics located in remote and rural areas. In this endeavor, Physicians for You has played a pivotal role by exploring innovative staffing solutions, addressing the unique challenges faced by healthcare clinics in these underserved regions.

Factors Influencing Physicians to Work in Remote Locations

Physicians for You recognizes the importance of understanding the factors that influence healthcare professionals to choose remote work. This understanding is crucial in designing effective solutions. Among the factors that drive healthcare professionals to work in remote locations are:

Ability to Practice a Wide Scope of Skills: Many healthcare professionals are drawn to remote areas due to the opportunity to practice a wide range of skills. In these regions, they often have the chance to serve in both hospital and community health settings, enhancing their professional growth and adaptability.

Opportunities for Continuity of Care: Remote clinics offer the possibility of providing continuity of care throughout a patient’s life. This personal and continuous relationship with patients can be a motivating factor for healthcare professionals committed to holistic healthcare.

The Challenge of Healthcare Delivery in Remote Areas

Geographic Barriers: Remote and rural areas often lack the infrastructure and accessibility found in urban centers. This geographic isolation can result in delayed or limited access to healthcare services, exacerbating health disparities. Physicians for You is acutely aware of the need to overcome these barriers to ensure equitable healthcare access.

Shortage of Healthcare Professionals: Healthcare professionals are often drawn to urban areas due to more varied career opportunities, higher salaries, and access to amenities. Rural and remote clinics frequently struggle with recruiting and retaining healthcare professionals. Physicians for You understands that innovative solutions are required to address this shortage and retain healthcare talent in remote areas.

Technology and Connectivity Issues: Remote clinics may face challenges related to limited access to modern healthcare technology and reliable internet connectivity. These limitations can hinder the adoption of telemedicine and other remote healthcare solutions. Physicians for You recognizes the importance of the medical field bridging this technology gap to ensure the efficacy of remote healthcare delivery.

Isolation and Burnout: Healthcare professionals in remote areas may experience feelings of isolation and burnout due to the limited social and professional support networks available in these locations. Physicians for You acknowledges the need to address the well-being of healthcare professionals working in remote areas.

Access more resources here: https://physiciansforyou.com/canada/blog.html

About Physicians for You

Physicians for You is a renowned provider of healthcare recruitment services, specializing in connecting clinics and healthcare institutions with top-tier talent. With a commitment to excellence, innovation, and diversity, the company strives to address the healthcare workforce shortages in Canada by providing customized staffing solutions that meet the unique needs of healthcare providers.

Media Contact
Company Name: Physicians For You
Contact Person: Hedaya Martin
Email: Send Email
Phone: +1 778 475 7995
Country: Canada
Website: https://www.physiciansforyou.com/

Essential Chiropractic Tips By Shaw Family Chiropractic Connecticut For Back Pain and Stress Relief

Shaw Family Chiropractic, LLC

Shaw Family Chiropractic, LLC invites residents of Southington CT to explore the benefits of chiropractic care.

Southington, Connecticut – Shaw Family Chiropractic, LLC, a trusted name in chiropractic care, continues to be a beacon of health and wellness for the Southington CT community. With a commitment to enhancing the lives of their patients, Shaw Family Chiropractic, LLC is sharing valuable tips for managing common ailments, such as back pain and stress relief. Chiropractic care plays a pivotal role in addressing various health concerns. Shaw Family Chiropractic, LLC, under the expert guidance of Dr. Robert Shaw, offers a range of chiropractic services that have proven effective in alleviating a multitude of ailments. Here are some tips related to back pain and stress relief, along with common issues chiropractors can help fix:

Proper Posture: Maintaining good posture is key to preventing back pain. Chiropractors Southington can educate patients on correct posture and offer adjustments to align the spine, reducing the strain on the back muscles.Ergonomic Workspace: Improper workspace ergonomics can lead to back pain and stress. Chiropractors can provide guidance on ergonomic setups to minimize discomfort during work hours.

Regular Exercise: Staying active is crucial for overall health. Chiropractors can recommend exercises that strengthen core muscles and promote spinal health, reducing the risk of back pain.

Stress Management: Chiropractic adjustments can help relieve tension and stress in the body. Regular sessions can contribute to improved mental and emotional well-being.

Nutrition: Chiropractors often provide nutritional advice to support overall health. Proper nutrition can aid in reducing inflammation and promoting healing.

Sciatica Relief: Chiropractic care is highly effective in addressing sciatica, a condition characterized by pain radiating down the leg. Adjustments can relieve pressure on the sciatic nerve, reducing discomfort.

Headache and Migraine Relief: Chiropractors can identify and address the root causes of headaches and migraines, offering non-invasive treatments to alleviate pain.

Neck Pain: Neck pain often results from poor posture or neck misalignment. Chiropractic adjustments can help realign the neck and provide relief.

Spinal Health: Chiropractors specialize in spinal manipulation and adjustments, promoting proper spinal alignment. This can address various ailments and improve overall health.

Joint Pain: Chiropractic care extends beyond the spine to include joint manipulation for issues such as knee and elbow pain, providing patients with holistic pain relief options.

Shaw Family Chiropractic, LLC invites residents of CT to explore the benefits of chiropractic care for these common ailments. With Dr. Robert Shaw’s extensive experience and commitment to improving the well-being of his patients, Shaw Family Chiropractic, LLC has become a trusted resource for those seeking relief from pain and stress.

For more information about Shaw Family Chiropractic, LLC and to schedule an appointment, please visit https://shawfamilychiropractic.com/chiropractor/southington/ or contact:

Media Contact
Company Name: Shaw Family Chiropractic, LLC
Contact Person: Dr. Robert Shaw
Email: Send Email
Phone: (860) 621-1919
Address:1783 Meriden-Waterbury Turnpike, Milldale
City: Southington
State: Connecticut 06467
Country: United States
Website: https://shawfamilychiropractic.com/

Knee Osteoarthritis Pipeline Medications (2023): FDA Approvals, Clinical Trials, Therapeutic Approaches, Mechanisms of Action, and Administration Routes by DelveInsight | Eupraxia Pharma, Techfields

“Knee Osteoarthritis Pipeline”

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 40+ key companies continuously working towards developing 40+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Knee Osteoarthritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

“Knee Osteoarthritis Pipeline Insight, 2023“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Knee Osteoarthritis Market.

Some of the key takeaways from the Knee Osteoarthritis Pipeline Report:

Companies across the globe are diligently working toward developing novel Knee Osteoarthritis treatment therapies with a considerable amount of success over the years.
Knee Osteoarthritis companies working in the treatment market are Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc, Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, Bioventus LLC, Genascence Corporation, Immunis, Inc., Novartis, Techfields Pharma Co. Ltd, Eli Lilly and Company, and others, are developing therapies for the Knee Osteoarthritis treatment

Emerging Knee Osteoarthritis therapies in the different phases of clinical trials are- M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, PTP-001, GNSC-001, IMM01-STEM, RHH646, X0002, Retatrutide, and others are expected to have a significant impact on the Knee Osteoarthritis market in the coming years.
In August 2023, “Exceptional results from our Phase 2b clinical trial of EP-104IAR for pain associated with knee osteoarthritis were announced during Eupraxia Pharmaceuticals Inc. second quarter,” said Dr. James Helliwell, CEO of Eupraxia. The EP-104IAR Phase 2b research is the largest in the organization’s history, and Eupraxia Pharmaceuticals thinks the results are a key barometer for the medication candidate and our underlying diffusion technology. Eupraxia Pharmaceuticals is collaborating with key opinion leaders to determine the best course of action for EP-104IAR based on the trial’s results and getting ready for an FDA End of Phase 2 meeting.
In December 2022, For its knee OA treatment candidate, lorecivivint (“LOR”), Biosplice Therapeutics, Inc. recently released possible structure-modifying highlights from the ongoing long-term extension study, OA-07. The study’s findings support the idea that frequent injections of lorecivivint may be effective in preventing structural progression and improving symptoms.
In August 2020, A long-term extension study was started by Biosplice Therapeutics to assess the effectiveness and safety of Lorecivivint in people with knee osteoarthritis. A long-term extension to the Phase III parent-study SM04690-OA-11 is intended by this study.

Knee Osteoarthritis Overview

The most typical type of arthritis is osteoarthritis (OA). Some people refer to it as “wear and tear” arthritis or degenerative joint disease. It usually affects the hands, hips, and knees. A joint’s cartilage starts to degrade and the underlying bone starts to change as a result of OA.

Get a Free Sample PDF Report to know more about Knee Osteoarthritis Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight

Emerging Knee Osteoarthritis Drugs Under Different Phases of Clinical Development Include:

M6495: Merck KGaA
PPV 06: Peptinov
LG00034053: LG Chem
StroMel: Akan Bioscience
TTAX03: BioTissue,Inc
EP-104IAR: Eupraxia Pharmaceuticals Inc.
OLP 1002: OliPass Corporation
JTA-004: Bone Therapeutics
X 0002: Techfields Pharma
Lorecivivint: Biosplice Therapeutics
PTP-001: Bioventus LLC
GNSC-001: Genascence Corporation
IMM01-STEM: Immunis, Inc.
RHH646: Novartis
X0002: Techfields Pharma Co. Ltd
Retatrutide: Eli Lilly and Company

Knee Osteoarthritis Route of Administration

Knee Osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Parenteral
Intravenous
Subcutaneous
Topical.
Molecule Type

Knee Osteoarthritis Molecule Type

Knee Osteoarthritis Products have been categorized under various Molecule types, such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy
Product Type

Knee Osteoarthritis Pipeline Therapeutics Assessment

Knee Osteoarthritis Assessment by Product Type
Knee Osteoarthritis By Stage and Product Type
Knee Osteoarthritis Assessment by Route of Administration
Knee Osteoarthritis By Stage and Route of Administration
Knee Osteoarthritis Assessment by Molecule Type
Knee Osteoarthritis by Stage and Molecule Type

DelveInsight’s Knee Osteoarthritis Report covers around 40+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Knee Osteoarthritis product details are provided in the report. Download the Knee Osteoarthritis pipeline report to learn more about the emerging Knee Osteoarthritis therapies

Some of the key companies in the Knee Osteoarthritis Therapeutics Market include:

Key companies developing therapies for Knee Osteoarthritis are – Bioventus LLC, Akan Biosciences, LLC, Genascence Corporation, Immunis, Inc., Novartis, Biosplice Therapeutics, Sorrento Therapeutics, Inc., Novartis, Celltex Therapeutics Corporation, MiMedx Group, Inc., Rho, Inc., Techfields Pharma Co. Ltd, Eli Lilly and Company, Nature Cell Co. Ltd., Novo Nordisk A/S, Flexion Therapeutics, Inc., Grünenthal GmbH, Tissue Tech Inc., Kolon TissueGene, Inc., Saol Therapeutics Inc, Centrexion Therapeutics, Taiwan Liposome Company, MiMedx, Ampio Pharmaceuticals, ReNu, Medipost, and others.

Knee Osteoarthritis Pipeline Analysis:

The Knee Osteoarthritis pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Knee Osteoarthritis with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis Treatment.
Knee Osteoarthritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Knee Osteoarthritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Knee Osteoarthritis market.

Download Sample PDF Report to know more about Knee Osteoarthritis drugs and therapies

Knee Osteoarthritis Pipeline Market Drivers

Increase in prevalence of Osteoarthritis, robust Pipeline are some of the important factors that are fueling the Knee Osteoarthritis Market.

Knee Osteoarthritis Pipeline Market Barriers

However , the risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment, high cost associated with the treatment and other factors are creating obstacles in the Knee Osteoarthritis Market growth.

Scope of Knee Osteoarthritis Pipeline Drug Insight

Coverage: Global
Key Knee Osteoarthritis Companies: Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc, Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, Bioventus LLC, Genascence Corporation, Immunis, Inc., Novartis, Techfields Pharma Co. Ltd, Eli Lilly and Company , and others
Key Knee Osteoarthritis Therapies: M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, PTP-001, GNSC-001, IMM01-STEM, RHH646, X0002, Retatrutide, and others
Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies
Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers

Request for Sample PDF Report for Knee Osteoarthritis Pipeline Assessment and clinical trials

Table of Contents

1. Knee Osteoarthritis Report Introduction

2. Knee Osteoarthritis Executive Summary

3. Knee Osteoarthritis Overview

4. Knee Osteoarthritis- Analytical Perspective In-depth Commercial Assessment

5. Knee Osteoarthritis Pipeline Therapeutics

6. Knee Osteoarthritis Late Stage Products (Phase II/III)

7. Knee Osteoarthritis Mid Stage Products (Phase II)

8. Knee Osteoarthritis Early Stage Products (Phase I)

9. Knee Osteoarthritis Preclinical Stage Products

10. Knee Osteoarthritis Therapeutics Assessment

11. Knee Osteoarthritis Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Knee Osteoarthritis Key Companies

14. Knee Osteoarthritis Key Products

15. Knee Osteoarthritis Unmet Needs

16 . Knee Osteoarthritis Market Drivers and Barriers

17. Knee Osteoarthritis Future Perspectives and Conclusion

18. Knee Osteoarthritis Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Knee Osteoarthritis Pipeline Medications (2023): FDA Approvals, Clinical Trials, Therapeutic Approaches, Mechanisms of Action, and Administration Routes by DelveInsight | Eupraxia Pharma, Techfields

NFT-UNIVERSE INC Receives $300 Million in Strategic Investment to Create a More Perfect Trading Experience for Digital Economy Consumers

On December 6, NFT-UNIVERSE, a global emerging NFT trading platform, completed a new round of financing of $300 million. This financing round was invested by crypto capital and well-known commercial finance banks. Following the completion of this round, the NFT-UNIVERSE team will continue to expand, enhance its technical capabilities, and optimize the trading environment, striving to create a more perfect trading experience for users and provide new services and development opportunities for global NFT enthusiasts.

NFTs, as digital assets that can flow into the real world, are continuously expanding and deepening their unique application scenarios in various fields. The emergence of NFT-UNIVERSE has also instantly ignited the NFT market. It provides services to professional NFT traders by offering more comprehensive trading functions and faster transaction speeds, attracting a large number of collectors and digital economy investors. NFT-UNIVERSE’s market share in NFT transaction volumes once exceeded 80%.

With the growing trend of NFTs and the surge in participants, various NFT platforms or projects are increasingly favored by capital. It’s not surprising that NFT-UNIVERSE received a $300 million strategic investment. Its reputation in the industry and media is commendable for its high-level layout of blockchain + content + community in the metaverse and NFT channels, creating a complete UGC content ecosystem. The platform maintains strict control over the quality of encrypted artworks and is open to everyone.

It is reported that this round of financing for NFT-UNIVERSE is expected to be completed in three phases by next summer. NFT-UNIVERSE will use these funds to expand its core platform, continue to develop points of presence globally, explore more business opportunities and partnerships, and achieve a win-win situation for the company and its customers. It will also continuously optimize advanced technologies such as big data, cloud computing, AI algorithms, and security encryption, unlocking more value for digital financial transactions.

NFT-UNIVERSE plans to continuously introduce new financial products and services to meet the needs of different investors and play a greater value in commercial applications. Leveraging blockchain’s storage and transaction mechanisms, NFTs on the platform are non-replicable, tamper-proof, and fully traceable, further creating unique digital assets. NFT-UNIVERSE can also accelerate the on-chain and digitization of physical assets, thereby further enhancing the value of the internet system from a global economic perspective.

In the era of Web3.0, NFT-UNIVERSE will uphold the trust and recognition of digital collectors, continuously build a low-friction, non-discriminatory trading environment, offer users a stronger sense of immersion and participation, and promote the entire industry by providing more people with opportunities to participate in the digital asset industry.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: NFT-UNIVERSE INC
Contact Person: Shirley
Email: Send Email
Country: United States
Website: https://nft-uni.com/

“The Marauder and His Daughter”: A Timeless Memoir of Merrill’s Marauders

Texas-based author Linda S. Cunningham is preparing to release her highly anticipated book, “The Marauder and His Daughter,” a captivating narrative that promises to engage readers, historians, and veterans alike. Set against the backdrop of World War II, this literary work delves deeply into themes of heroism, sacrifice, and enduring love.

For historians, the book offers a meticulous and detailed account of Merrill’s Marauders’ experiences. By drawing heavily from her father’s war diary, Cunningham provides a unique and vivid perspective on one of the most secretive missions of World War II. This meticulously researched work adds valuable insight to the historical narrative, illuminating untold stories often lost in traditional accounts.

Veterans will find “The Marauder and His Daughter” a poignant tribute to the unwavering spirit of those who faced the harsh realities of war. Cunningham’s narrative not only honors their sacrifices but also captures the essence of comradeship and patriotism that defines the veteran experience. This compelling tale resonates deeply with those who have served, making it a must-read for anyone connected to military history.

“The Marauder and his Daughter” is an excellent read for anyone seeking to build a connection with a cherished past that has faded from the pages of history. Through the emotional impact of her father’s wartime diary, the book vividly portrays the struggles, sacrifices, and unwavering love that sustained the family during turbulent times. It serves as a testament to the resilience of the human spirit in the face of adversity.

Set against the backdrop of World War II, “The Marauder and His Daughter” chronicles the extraordinary journey of a decorated soldier and his beloved daughter. Through their eyes, witness the horrors and triumphs of war, the unwavering strength of family, and the enduring power of the human spirit.

Get a copy now and be among the first to experience this extraordinary story.

https://a.co/d/iFDfqxO https://lindascunningham.com/

Media Contact
Company Name: Linda S. Cunningham
Contact Person: Mark Rivera
Email: Send Email
Country: United States
Website: https://lindascunningham.com/